middle.news
Paradigm Activates First Australian Site, Enrolls Initial Patient in Phase 3 Knee OA Trial
8:50am on Tuesday 3rd of June, 2025 AEST
•
Healthcare
Read Story
Paradigm Activates First Australian Site, Enrolls Initial Patient in Phase 3 Knee OA Trial
8:50am on Tuesday 3rd of June, 2025 AEST
Key Points
First Australian clinical site activated at Sportsmed Biologic, Melbourne
First Australian patient consented for Phase 3 knee osteoarthritis trial
11 Australian and 48 US sites selected and preparing for activation
Trial evaluates injectable pentosan polysulfate sodium (iPPS) for knee OA pain
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Paradigm Biopharmaceuticals (ASX:PAR)
OPEN ARTICLE